Emergent BioSolutions, Inc. (EBS)
8.08
-0.13
(-1.58%)
USD |
NYSE |
Mar 26, 16:00
8.01
-0.07
(-0.87%)
Pre-Market: 05:41
Emergent BioSolutions Cash from Investing (Quarterly) : -3.90M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -512.00M |
| Eli Lilly & Co. | -2.802B |
| Penumbra, Inc. | -225.65M |
| Disc Medicine, Inc. | -222.89M |
| MetaVia, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 77.70M |
| Cash from Financing (Quarterly) | -113.90M |
| Free Cash Flow | 156.80M |
| Free Cash Flow Per Share (Quarterly) | 1.408 |
| Free Cash Flow to Equity (Quarterly) | 161.10M |
| Free Cash Flow to Firm (Quarterly) | 89.63M |
| Free Cash Flow Yield | 35.22% |